PROMEDITECH
ActiveSummary
The computed 12-month bankruptcy probability of PROMEDITECH is 1.6% (moderate). The 2024 annual accounts show equity of €81,239 and a net result of -€1,805. Equity is shrinking by ~6.1% per year across the filed fiscal years. Its solvency ranks better than 61% of 6550 sector peers (fiscal year 2024). The company has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
Axes · tick = 2023
Profitability35▲+1
Solvency67▼-2
Growth58=
Track record100
Bankruptcy probability, 12 months
1.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,500 at 30 days acceptable
Liquidity short (current ratio 0.59 against 0.59 in 2023; short-term debt: 56.8% and cash: 32.2% of total assets), and 57.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
42.3%
Return on assets
-0.9%
Age of the figures
21 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 20-06-2025, 41 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
41 d early
2023
27 d early
2022
41 d early
2021
34 d early
2020
45 d early
2019
56 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 41 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€1,805▲ 22.7%
2023 · -€2,335
Working capital
-€44,182▼ 0.2%
2023 · -€44,115
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result-€6,848▼ 0.1%-€7,038▼ 2.8%-€7,258▼ 3.1%-€2,361▲ 67.5%-€1,836▲ 22.2%
Net result-€6,969below the sector's middle half▼ 0.3%-€7,194below the sector's middle half▼ 3.2%-€7,458below the sector's middle half▼ 3.7%-€2,335below the sector's middle half▲ 68.7%-€1,805within the sector's middle half▲ 22.7%
Equity€100,031within the sector's middle half▼ 6.5%€92,837within the sector's middle half▼ 7.2%€85,379within the sector's middle half▼ 8.0%€83,044within the sector's middle half▼ 2.7%€81,239within the sector's middle half▼ 2.2%
Total assets€207,423within the sector's middle half▼ 3.2%€200,303within the sector's middle half▼ 3.4%€193,005within the sector's middle half▼ 3.6%€190,682below the sector's middle half▼ 1.2%€191,967below the sector's middle half▲ 0.7%
Debt€107,391=€107,466▲ 0.1%€107,625▲ 0.1%€107,638=€110,728▲ 2.9%
Working capital-€26,858below the sector's middle half▼ 43.6%-€34,322below the sector's middle half▼ 27.8%-€41,780below the sector's middle half▼ 21.7%-€44,115below the sector's middle half▼ 5.6%-€44,182below the sector's middle half▼ 0.2%
Solvency48.2%within the sector's middle half▼ 1.7pp46.3%within the sector's middle half▼ 1.9pp44.2%within the sector's middle half▼ 2.1pp43.6%within the sector's middle half▼ 0.7pp42.3%within the sector's middle half▼ 1.2pp
Current ratio0.75below the sector's middle half▼ 0.070.68below the sector's middle half▼ 0.070.61below the sector's middle half▼ 0.070.59below the sector's middle half▼ 0.020.59below the sector's middle half=
Return on assets (ROA)-3.4%below the sector's middle half▼ 0.1pp-3.6%below the sector's middle half▼ 0.2pp-3.9%below the sector's middle half▼ 0.3pp-1.2%below the sector's middle half▲ 2.6pp-0.9%below the sector's middle half▲ 0.3pp
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €1,836 in 2024 against €2,361 in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €191,967
Fixed assets
€127,159 =
Current assets
€64,808 ▲ 2.0%
Equity and liabilities €191,967
Equity
€81,239 ▼ 2.2%
Debt
€110,728 ▲ 2.9%
Debt's share of the balance-sheet total rises from 56.4% to 57.7%. Equity is lower and debt is higher.
Key figures and ratios
Debt to equity
1.36▲
2023 · 1.30
ROE
-2.2%▲
2023 · -2.8%
Debt ≤ 1 year
€108,990▲
2023 · €107,638
Income taxes
€0=
2023 · €0
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | €448 | €348 | €384 | €387 | ▲ 0.8% |
| Gross operating margin9900 | -€6,500 | -€6,590 | -€6,910 | -€1,977 | -€1,449 | ▲ 26.7% |
| Operating profit (loss)9901 | -€6,848 | -€7,038 | -€7,258 | -€2,361 | -€1,836 | ▲ 22.2% |
| Financial income75/76B | - | - | €13 | €225 | €253 | ▲ 12.4% |
| Recurring financial income75 | €4 | - | €13 | €225 | €253 | ▲ 12.4% |
| Financial charges65/66B | - | €157 | €214 | €199 | €222 | ▲ 11.7% |
| Recurring financial charges65 | €126 | €157 | €214 | €199 | €222 | ▲ 11.7% |
| Profit (loss) for the period before taxes9903 | -€6,969 | -€7,194 | -€7,458 | -€2,335 | -€1,805 | ▲ 22.7% |
| Income taxes67/77 | - | - | - | €0 | €0 | - |
| Profit (loss) for the period9904 | -€6,969 | -€7,194 | -€7,458 | -€2,335 | -€1,805 | ▲ 22.7% |
| Profit (loss) for the period to be appropriated9905 | -€6,969 | -€7,194 | -€7,458 | -€2,335 | -€1,805 | ▲ 22.7% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €207,423 | €200,303 | €193,005 | €190,682 | €191,967 | ▲ 0.7% |
| Fixed assets21/28 | €127,159 | €127,159 | €127,159 | €127,159 | €127,159 | = |
| Financial fixed assets28 | €127,159 | €127,159 | €127,159 | €127,159 | €127,159 | = |
| Current assets29/58 | €80,264 | €73,144 | €65,846 | €63,523 | €64,808 | ▲ 2.0% |
| Amounts receivable within one year40/41 | €248 | €664 | €543 | €5,842 | €1,420 | ▼ 75.7% |
| Trade receivables40 | - | - | - | €4,500 | €0 | ▼ 100% |
| Other amounts receivable41 | - | €664 | €543 | €1,342 | €1,420 | ▲ 5.8% |
| Cash at bank and in hand54/58 | €80,015 | €72,480 | €65,290 | €57,618 | €61,824 | ▲ 7.3% |
| Deferred charges and accrued income490/1 | - | - | €13 | €63 | €1,564 | ▲ 2,365% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €207,423 | €200,303 | €193,005 | €190,682 | €191,967 | ▲ 0.7% |
| Equity10/15 | €100,031 | €92,837 | €85,379 | €83,044 | €81,239 | ▼ 2.2% |
| Contributions10/11 | - | €53,600 | €53,600 | €53,600 | €53,600 | = |
| Reserves13 | €5,360 | €5,360 | €5,360 | €5,360 | €5,360 | = |
| Non-distributable reserves130/1 | - | €5,360 | €5,360 | €5,360 | €5,360 | = |
| Reserves not available under the articles1311 | - | €5,360 | €5,360 | €5,360 | €5,360 | = |
| Profit (loss) carried forward14 | €41,071 | €33,877 | €26,419 | €24,084 | €22,279 | ▼ 7.5% |
| Amounts payable17/49 | €107,391 | €107,466 | €107,625 | €107,638 | €110,728 | ▲ 2.9% |
| Amounts payable within one year42/48 | €107,121 | €107,466 | €107,625 | €107,638 | €108,990 | ▲ 1.3% |
| Trade debts44 | €1,191 | €1,535 | €1,695 | €1,707 | €3,031 | ▲ 77.5% |
| Suppliers440/4 | - | €1,535 | €1,695 | €1,707 | €3,031 | ▲ 77.5% |
| Other amounts payable47/48 | - | €105,931 | €105,931 | €105,931 | €105,960 | = |
| Accrued charges and deferred income492/3 | - | - | - | - | €1,738 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€6,969 | -€7,194 | -€7,458 | -€2,335 | -€1,805 | ▲ 22.7% |
| Operating cash flow (approximation) | -€6,969 | -€7,194 | -€7,458 | -€2,335 | -€1,805 | ▲ 22.7% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | -€7,535 | -€7,190 | -€7,672 | €4,207 | ▲ 155% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
20-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
04-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
20-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet -€7,458
Net result drops to -€7,458, the lowest in the series; recovery starts the following year.
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
16-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
05-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
12-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
12-06
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
13-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
2016
01-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2008
Ground area
873 m²
Building footprint
335 m²
Volume, LiDAR
1,815 m³
Parcel 21821B0379/00Y000, Brussels · tallest building 7.9 m, ±2 floors. Linked by address, not a title deed.
11
companies at this address
See who is registered here
1 establishment unit
PROMEDITECH
since 20082.198.948.923
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21821B0379/00Y000 | Brussels | 873 m² | 1 · 335 m² | 7.9 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2024 list no shareholders, and no other source names one.
Holdings 1
-
100%
According to the 2024 annual accounts of PROMEDITECH and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
PHARMACIE MONTENEGRO
BE 0764.411.765
Anderlecht · Eq €81,129
APOTHEEK CANDIDE JACOBS
BE 0446.153.874
De Haan · Eq €81,383
PHARMA-SEILLES
BE 0464.296.438
Andenne · Eq €81,412
Quality Pharmaceutical Service
BE 1009.819.983
La Bruyère · Eq €80,895
J. Veys Pharma
BE 0804.880.858
Waregem · Eq €81,597
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,255 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded20-10-2008
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0807225387
Also
9925:BE0807225387
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.